Myopia is a refractive error (blurred vision at a given distance) that affects about 30% of the world's population. This ...

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

Brianna Rhue, OD, FAAO, discusses the pitfalls of myopia treatment and accessibility of that treatment. There are still some ...

Korean adults with stable myopic normal-tension glaucoma who had not received IOP-lowering treatment for at least 1 year were ...

Gawne's research will utilize animal models, and findings could translate to human applications, potentially revolutionizing myopia prevention and treatment. His dedication to this research is driven ...

Get Regular Eye Checkups – Early detection of myopia can help manage it better with glasses, contact lenses, or other treatments. Digital devices are an unavoidable part of modern life ...

FDA assigns a PDUFA target action date of October 23, 2025 If approved, SYD-101 would be the first and only pharmaceutical treatment option proven to slow the progression of pediatric myopia ...

Glaucoma and cataracts can occur more quickly, and their association with high myopia makes their treatment much more complex. The main condition that can lead to blindness in nearsighted people ...